(Q36823774)

16 August 2017

1 reference

title

Silent myocardial ischemia screening in patients with diabetes mellitus (English)

1 reference

silent myocardial ischemia

16 August 2017

main subject

1 reference

Olivier Barthelemy

1

1 reference

16 August 2017

Claude Le Feuvre

series ordinal

2

1 reference

16 August 2017

José Timsit

series ordinal

3

1 reference

16 August 2017

publication date

1 March 2007

1 reference

Arquivos Brasileiros de Endocrinologia e Metabologia

16 August 2017

published in

1 reference

16 August 2017

volume

51

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

285-293

1 reference

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Diabetes and cardiovascular disease. The Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Prevalence of asymptomatic myocardial ischaemia in diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Cardiovascular effects of rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularisation Therapies Study part II (ARTS II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Abciximab reduces mortality in diabetics following percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Mortality over a period of 10 years in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Prognostic value of dobutamine stress echocardiography in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000200018

10.1590/S0004-27302007000200018

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference